Tamiflu (oseltamivir) is a go-to antiviral for the flu, but it’s not the only choice. Maybe it caused side effects, wasn’t available, or your doctor suspects resistance. This page explains common alternatives, how they differ, and simple rules for picking the right option.
Zanamivir (brand: Relenza) is an inhaled antiviral that works like Tamiflu but is breathed into the lungs. It can be a good option for people who can’t tolerate oral meds. Don’t use zanamivir if you have asthma or COPD—its inhaled form can trigger breathing problems.
Baloxavir marboxil (brand: Xofluza) is a single-dose pill that stops the virus differently than Tamiflu. One dose can shorten symptoms and reduce virus spread in a household. It’s convenient, but doctors watch for treatment failures in certain groups and may avoid it for some patients.
Peramivir (brand: Rapivab) is given intravenously in a clinic or hospital. It’s useful for people who can’t take oral meds or have severe flu that requires close monitoring. Because it’s IV, you’ll get it under medical supervision.
Vaccination remains the best prevention. Seasonal flu shots lower your chance of severe illness and reduce the need for antivirals. If you do get sick, early treatment matters—antivirals work best within 48 hours of symptoms starting, though doctors may still use them later for high-risk patients.
Supportive care helps a lot: rest, fluids, fever control with acetaminophen or ibuprofen, and keeping up nutrition. For people at high risk (older adults, pregnant people, people with chronic illness), call your clinician early. They may choose an IV option or prescribe antivirals even after the 48-hour window.
Drug choice depends on health, age, and breathing status. For example, inhaled zanamivir is off-limits if you have wheeze or lung disease. Single-dose baloxavir is handy for busy people, but check with your doctor if you take other drugs, since interactions are possible. Peramivir is for sicker patients who need a hospital visit.
Watch for side effects. Nausea and vomiting are common with oral antivirals. Zanamivir may cause cough or breathing trouble. Report severe side effects or worsening symptoms right away. Also, if one antiviral doesn’t help, doctors may switch to another depending on test results and clinical response.
Bottom line: Tamiflu isn’t the only tool against influenza. Zanamivir, baloxavir, and peramivir fill different needs—mild outpatient care, single-dose convenience, or severe cases needing IV treatment. Ask your healthcare provider which option fits your situation, and don’t delay care if you’re high risk or getting worse.
Looking beyond Tamiflu in 2025: Explore baloxavir, peramivir, and practical supportive care strategies for flu. Which option suits you best this season?
Medications